Error in Figure/Table
In the original article, there was a mistake in Table 2 as published. Alleles of rs4343 polymorphism were incorrectly written. The corrected Table 2 appears below.
Table 2
| rs4341 | ||||
|---|---|---|---|---|
| Hypertension | G/G | G/C | C/C | P-value |
| Hospital ward | 6 (20%) | 16 (53.3%) | 8 (26.7%) | 0.031* |
| ICU | 6 (50%) | 5 (41.7%) | 1 (8.3%) | 0.03$ |
| Dyslipidemia | G/G | G/C | C/C | P-value |
| Hospital ward | 2 (15.4%) | 6 (46.1%) | 5 (38.5%) | 0.043* |
| ICU | 4 (57.1%) | 3 (42,9%) | 0 (0%) | |
| Diabetes Mellitus | G/G | G/C | C/C | P-value |
| Hospital ward | 1 (8.3%) | 7 (58.3%) | 4 (33.3%) | 0.033* |
| ICU | 3 (100%) | 0 (0%) | 0 (0%) | 0.009$ |
| rs4343 | ||||
| Hypertension | G/G | G/A | A/A | P-value |
| Hospital ward | 15 (16.6%) | 17 (56.7%) | 8 (26.7%) | 0.03% |
| ICU | 5 (41.7%) | 6 (50%) | 1 (8.3%) | |
| Dyslipidemia | G/G | G/A | A/A | P-value |
| Hospital ward | 2 (15.4%) | 6 (46.1%) | 5 (38.5%) | 0.043# |
| ICU | 4 (57.1%) | 3 (42,9%) | 0 (0%) | |
| Diabetes Mellitus | G/G | G/A | A/A | P-value |
| Hospital ward | 1 (8.3%) | 7 (58.3%) | 4 (33.3%) | 0.033# |
| ICU | 3 (100%) | 0 (0%) | 0 (0%) | 0.009% |
Genotype frequencies of rs4341 and rs4343 polymorphisms in COVID-19 patients according to its hypertensive, dyslipidemic or diabetic status.
Data are presented as number of patients and percentages.
*p-value for group difference between GG and GC and CC.
$p-value for group difference between GG+GC and CC.
#p-value for group difference between GG+GA and AA.
%p-value for group difference between GG+GA and AA.
Significant differences appear in bold case.
All data were adjusted for age, sex, BMI and number of comorbidities.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
COVID-19, angiotensin converting enzyme, polymorphisms, hypertension, dyslipidemia, diabetes
Citation
Íñiguez M, Pérez-Matute P, Villoslada-Blanco P, Recio-Fernandez E, Ezquerro-Pérez D, Alba J, Ferreira-Laso ML and Oteo JA (2021) Corrigendum: ACE Gene Variants Rise the Risk of Severe COVID-19 in Patients With Hypertension, Dyslipidemia or Diabetes: A Spanish Pilot Study. Front. Endocrinol. 12:771445. doi: 10.3389/fendo.2021.771445
Received
06 September 2021
Accepted
08 September 2021
Published
20 September 2021
Volume
12 - 2021
Edited and reviewed by
Hamad Ali, Kuwait University, Kuwait
Updates
Copyright
© 2021 Íñiguez, Pérez-Matute, Villoslada-Blanco, Recio-Fernandez, Ezquerro-Pérez, Alba, Ferreira-Laso and Oteo.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: José A. Oteo, jaoteo@riojasalud.es
This article was submitted to Clinical Diabetes, a section of the journal Frontiers in Endocrinology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.